New England Capital Financial Advisors’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$13.5K Buy
147
+1
+0.7% +$87 ﹤0.01% 241
2026
Q1
$12.5K Buy
146
+1
+0.7% +$89 ﹤0.01% 237
2025
Q4
$11.5K Buy
145
+1
+0.7% +$78 ﹤0.01% 249
2025
Q3
$11.5K Hold
144
﹤0.01% 245
2025
Q2
$13K Buy
144
+1
+0.7% +$91 0.01% 219
2025
Q1
$13.4K Buy
143
+1
+0.7% +$90 0.01% 208
2024
Q4
$12.9K Buy
142
+1
+0.7% +$95 0.01% 216
2024
Q3
$14.6K Buy
141
+1
+0.7% +$102 0.01% 205
2024
Q2
$13.6K Hold
140
0.01% 208
2024
Q1
$12.6K Buy
140
+1
+0.7% +$85 0.01% 213
2023
Q4
$11.1K Buy
139
+1
+0.7% +$75 0.01% 224
2023
Q3
$9.81K Buy
138
+1
+0.7% +$75 0.01% 227
2023
Q2
$10.6K Buy
137
+1
+0.7% +$77 0.01% 221
2023
Q1
$10.2K Buy
136
+1
+0.7% +$74 0.01% 244
2022
Q4
$10.2K Buy
+135
New +$10.1K 0.01% 251

Other funds holding CL

New England Capital Financial Advisors's CL Position: Q2 2026 in Review

New England Capital Financial Advisors increased its Colgate-Palmolive (CL) stake by 0.68% in Q2 2026, buying an estimated $87 and bringing the position to 147 shares worth $13.5K. The position accounts for ﹤0.01% of the portfolio, ranked #241.

New England Capital Financial Advisors first reported a position in CL in Q4 2022 and has held it in 15 quarters since. The position peaked at $14.6K in Q3 2024. 665 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • New England Capital Financial Advisors held 147 shares of Colgate-Palmolive worth $13.5K as of Q2 2026.
  • New England Capital Financial Advisors bought 1 Colgate-Palmolive share in Q2 2026, an estimated $87.
  • Colgate-Palmolive made up ﹤0.01% of New England Capital Financial Advisors's portfolio in Q2 2026, its #241 holding.
  • New England Capital Financial Advisors first reported a position in Colgate-Palmolive in Q4 2022 and has held it in 15 quarters since.
  • New England Capital Financial Advisors's Colgate-Palmolive position peaked at $14.6K in Q3 2024.
  • 665 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on New England Capital Financial Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.